Historique
Bulletin de Périodique
Addiction , Vol.105, n°6 - June 2010
Paru le :
01/06/2010
Année
2010
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study. Griffiths P., Sedefov R., Gallegos A., Lopez D., p. 951-953.
- Brief alcohol intervention--where to from here? Challenges remain for research and practice. Nilsen P., p. 954-959.
- Brief alcohol intervention: time for translational research. Kaner E., p. 960-961; discussion 964-965.
- Unexplored territories. Allamani A., p. 961-963; discussion 964-965.
- Meeting the challenges for research and practice for brief alcohol intervention. Moyer A., Finney J.W., p. 963-964; discussion 964-965.
- Addiction research centres and the nurturing of creativity. University of Michigan Addiction Research Center (UMARC): development, evolution, and direction. Zucker R.A., p. 966-973.
- 'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction. Gundle K.R., Dingel M.J., Koenig B.A., p. 974-983.
- Seeing America--diary of a drug-focused study tour made in 1967. Edwards G., p. 984-990.
- Health outcomes associated with methamphetamine use among young people: a systematic review. Marshall B.D., Werb D., p. 991-1002.
- Commentary on Marshall et al. (2010): are long-term negative health consequences of methamphetamine use important to youth? Rawson R.A., Gonzales R., p. 1003-1004.
- Modeling missing binary outcome data in a successful web-based smokeless tobacco cessation program. Smolkowski K., Danaher B.G., Seeley J.R., Kosty D.B., Severson H.H., p. 1005-1015.
- Commentary on Smolkowski et al. (2010): why is it important to assume that non-responders in tobacco cessation trials have relapsed? Hajek P., West R., p. 1016-1017.
- Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006. Rey G., Boniol M., Jougla E., p. 1018-1029.
- Commentary on Rey et al. (2010): how to improve estimates on alcohol-attributable burden? Rehm J., p. 1030-1031.
- Effects of a community intervention to reduce the serving of alcohol to intoxicated patrons. Warpenius K., Holmila M., Mustonen H., p. 1032-1040.
- Rumination as a predictor of drinking behaviour in alcohol abusers: a prospective study. Caselli G., Ferretti C., Leoni M., Rebecchi D., Rovetto F., Spada M.M., p. 1041-1048.
- Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006. Bohnert A.S., Prescott M.R., Vlahov D., Tardiff K.J., Galea S., p. 1049-1054.
- Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Wisaksana R., Indrati A.K., Fibriani A., Rogayah E., Sudjana P., Djajakusumah T.S., et al., p. 1055-1061.
- Flashblood: blood sharing among female injecting drug users in Tanzania. Mccurdy S.A., Ross M.W., Williams M.L., Kilonzo G.P., Leshabari M.T., p. 1062-1070.
- The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Roxburgh A., Hall W.D., Degenhardt L., Mclaren J., Black E., Copeland J., et al., p. 1071-1079.
- Impairment due to cannabis and ethanol: clinical signs and additive effects. Bramness J.G., Khiabani H.Z., Morland J., p. 1080-1087.
- If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands. Vemer P., Rutten-Van Molken M.P., Kaper J., Hoogenveen R.T., Van Schayck C.P., Feenstra T.L., p. 1088-1097.
- Commentary on Vemer et al. (2010): when is smoking cessation really cost-effective? Salize H.J., p. 1098-1099.
- Risk perception and smoking behavior in medically ill smokers: a prospective study. Borrelli B., Hayes R.B., Dunsiger S., Fava J.L., p. 1100-1108.
- Predicting the life-time benefit of school-based smoking prevention programmes. Jit M., Aveyard P., Barton P., Meads C.A., p. 1109-1116.
- Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Swendsen J., Conway K.P., Degenhardt L., Glantz M., Jin R., Merikangas K.R., et al., p. 1117-1128.
- Mephentermine dependence without psychosis: a Brazilian case report. De Sousa H.F., De Oliveira M.F., Da Costa Lima M.D., De Oliveira J.R., p. 1129-1130.
- How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study. Griffiths P., Sedefov R., Gallegos A., Lopez D., p. 951-953.
- Brief alcohol intervention--where to from here? Challenges remain for research and practice. Nilsen P., p. 954-959.
- Brief alcohol intervention: time for translational research. Kaner E., p. 960-961; discussion 964-965.
- Unexplored territories. Allamani A., p. 961-963; discussion 964-965.
- Meeting the challenges for research and practice for brief alcohol intervention. Moyer A., Finney J.W., p. 963-964; discussion 964-965.
- Addiction research centres and the nurturing of creativity. University of Michigan Addiction Research Center (UMARC): development, evolution, and direction. Zucker R.A., p. 966-973.
- 'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction. Gundle K.R., Dingel M.J., Koenig B.A., p. 974-983.
- Seeing America--diary of a drug-focused study tour made in 1967. Edwards G., p. 984-990.
- Health outcomes associated with methamphetamine use among young people: a systematic review. Marshall B.D., Werb D., p. 991-1002.
- Commentary on Marshall et al. (2010): are long-term negative health consequences of methamphetamine use important to youth? Rawson R.A., Gonzales R., p. 1003-1004.
- Modeling missing binary outcome data in a successful web-based smokeless tobacco cessation program. Smolkowski K., Danaher B.G., Seeley J.R., Kosty D.B., Severson H.H., p. 1005-1015.
- Commentary on Smolkowski et al. (2010): why is it important to assume that non-responders in tobacco cessation trials have relapsed? Hajek P., West R., p. 1016-1017.
- Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006. Rey G., Boniol M., Jougla E., p. 1018-1029.
- Commentary on Rey et al. (2010): how to improve estimates on alcohol-attributable burden? Rehm J., p. 1030-1031.
- Effects of a community intervention to reduce the serving of alcohol to intoxicated patrons. Warpenius K., Holmila M., Mustonen H., p. 1032-1040.
- Rumination as a predictor of drinking behaviour in alcohol abusers: a prospective study. Caselli G., Ferretti C., Leoni M., Rebecchi D., Rovetto F., Spada M.M., p. 1041-1048.
- Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006. Bohnert A.S., Prescott M.R., Vlahov D., Tardiff K.J., Galea S., p. 1049-1054.
- Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Wisaksana R., Indrati A.K., Fibriani A., Rogayah E., Sudjana P., Djajakusumah T.S., et al., p. 1055-1061.
- Flashblood: blood sharing among female injecting drug users in Tanzania. Mccurdy S.A., Ross M.W., Williams M.L., Kilonzo G.P., Leshabari M.T., p. 1062-1070.
- The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Roxburgh A., Hall W.D., Degenhardt L., Mclaren J., Black E., Copeland J., et al., p. 1071-1079.
- Impairment due to cannabis and ethanol: clinical signs and additive effects. Bramness J.G., Khiabani H.Z., Morland J., p. 1080-1087.
- If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands. Vemer P., Rutten-Van Molken M.P., Kaper J., Hoogenveen R.T., Van Schayck C.P., Feenstra T.L., p. 1088-1097.
- Commentary on Vemer et al. (2010): when is smoking cessation really cost-effective? Salize H.J., p. 1098-1099.
- Risk perception and smoking behavior in medically ill smokers: a prospective study. Borrelli B., Hayes R.B., Dunsiger S., Fava J.L., p. 1100-1108.
- Predicting the life-time benefit of school-based smoking prevention programmes. Jit M., Aveyard P., Barton P., Meads C.A., p. 1109-1116.
- Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Swendsen J., Conway K.P., Degenhardt L., Glantz M., Jin R., Merikangas K.R., et al., p. 1117-1128.
- Mephentermine dependence without psychosis: a Brazilian case report. De Sousa H.F., De Oliveira M.F., Da Costa Lima M.D., De Oliveira J.R., p. 1129-1130.
Dépouillements
Ajouter le résultat à votre sélection
Aims: Computing the number of alcohol-attributable deaths requires a series of hypotheses. Using French data for 2006, the potential biases are reviewed and the sensitivity of estimates to various hypotheses evaluated.
Methods: Self-reported al[...]
![How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study [Editorial]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_73046.webp?v=1771277053)
P. GRIFFITHS ;
R. SEDEFOV ;
A. GALLEGOS ;
D. LOPEZ
|
2010
Dans Addiction (Vol.105, n°6, June 2010) Article : Périodique
Dans Addiction (Vol.105, n°6, June 2010) Article : Périodique
'Spice' is a herbal mixture sold on the internet, samples of which have been found to contain new synthetic drugs which produce effects similar to cannabis. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)'s early warning sys[...]